$56.920
+0.102 (+0.18%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de CRSP por análisis de gráficos similares
Alphio's CRSP stock price prediction model matches the current CRISPR Therapeutics AG tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $57.02 (+0.93%). The 1-week path is $56.40 (-0.16%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de CRISPR Therapeutics AG?
CRISPR Therapeutics AG (CRSP) is a good buy right now due to its recent positive trial results for CTX310, which showed a 79% reduction in ANGPTL3 levels and significant decreases in triglycerides and LDL cholesterol. The stock is currently priced at $57.72, with a forward P/E ratio of 23.36, indicating potential for growth as the company expands its pipeline. However, the main risk is the high insider selling activity, which has increased by 476.16% over the last month, suggesting caution from insiders.
CRSP cerró en $56.92 el Wednesday, tras subir +0.18%
CRISPR Therapeutics AG (CRSP) last closed at $56.49, losing -0.76%. These facts feed the 1-day and 1-week CRSP price prediction above.
Consenso de analistas
CRISPR Therapeutics AG (CRSP): 3 comprar, 3 mantener, 0 vender. Perspectiva: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de CRISPR Therapeutics AG (CRSP) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de CRSP, ordenadas por similitud.
Análisis de estacionalidad de CRSP
Historically the probability of a positive September return for CRSP is 54.55%. March offers the highest probability of a positive month at 61.90%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de CRSP
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Sep 2026 | $22.73 | $37.13 | $47.22 | -34.26% |
| Oct 2026 | $17.82 | $33.96 | $51.74 | -39.89% |
| Nov 2026 | $29.09 | $38.88 | $44.05 | -31.17% |
| Dec 2026 | $37.57 | $46.16 | $57.97 | -18.28% |
En 2026, se proyecta que CRISPR Therapeutics AG (CRSP) oscile entre $17.82 y $57.97.
Previsión mensual de CRISPR Therapeutics AG para 2026
En Sep de 2026, se proyecta que CRISPR Therapeutics AG promedie $37.13, con un mínimo de $22.73 y un máximo de $47.22.
En Oct de 2026, se proyecta que CRISPR Therapeutics AG promedie $33.96, con un mínimo de $17.82 y un máximo de $51.74.
En Nov de 2026, se proyecta que CRISPR Therapeutics AG promedie $38.88, con un mínimo de $29.09 y un máximo de $44.05.
En Dec de 2026, se proyecta que CRISPR Therapeutics AG promedie $46.16, con un mínimo de $37.57 y un máximo de $57.97.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.